NOTCH1 and ischemic disease: Due to its overexpression, c-Notch1 (Notch homolog 1, translocation-associated) levels and its downstream signaling pathways are enhanced, suggesting that CatK could contribute to Notch1-dependent neovascularization and be a potential therapeutic target for ischemic disease [58].